Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

NCT02419742 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Doxorubicin
DRUG: Paclitaxel
DRUG: Trastuzumab

Sponsor

Hoffmann-La Roche